
zzso highly zzso chemotherapy zzso displays a zzso pattern of zzso with both an early and delayed zzso In contrast, moderately zzso chemotherapy zzso has a zzso zzso The objective of this analysis was to further investigate the impact of the zzso zzso zzso on these zzso 

Three phase III zzso zzso scheduled to receive zzso zzso and one phase III zzso zzso cancer patients scheduled to receive zzso plus zzso zzso trials of zzso were zzso In all studies, patients were zzso in a zzso ratio to an zzso regimen zzso plus zzso plus zzso or the standard regimen zzso plus zzso The exact dosing regimen for zzso and zzso was different in each zzso In a post hoc analysis, zzso zzso zzso models were used to assess the impact on first zzso at different time intervals after zzso 

One thousand five hundred zzso patients and zzso patients were zzso and assessed for efficacy in the zzso and zzso trials, zzso For zzso zzso reduced the risk of first zzso by zzso zzso standard regimen, beginning 15-18 h after zzso and extending to 60 zzso For zzso zzso reduced the risk of first zzso by zzso zzso active control, beginning 3 h after zzso and for up to 12 zzso 

Time of onset and duration of enhanced control of zzso with the addition of zzso differed between zzso and zzso This suggests that the pattern of zzso mechanisms may vary for different chemotherapy zzso 

